US Autoimmunity Diagnostics Market (2025-2030)
The US Autoimmunity Diagnostics Market was valued at $1119 Million in 2025 and projected to reach to $1759.4 Million by 2030, representing a compound annual growth rate of 7.8%. The US autoimmunity diagnostics market is poised for sustained growth through 2030, driven by increasing disease prevalence, heightened awareness among healthcare providers, and patient demand for accurate early diagnosis.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Autoimmunity Diagnostics Market Trends and Insights
- The US market is driven by rising prevalence of autoimmune disorders, increased healthcare spending, and growing adoption of advanced diagnostic technologies.
- In the US, the demand for early detection and accurate diagnosis of conditions such as rheumatoid arthritis, lupus, and celiac disease continues to accelerate market growth. The US autoimmunity diagnostics sector benefits from robust reimbursement policies, a well-established healthcare infrastructure, and significant investment in research and development.
- The US market is characterized by the presence of leading diagnostic manufacturers and a high volume of clinical testing.
- Between 2025 and 2030, the US is expected to see increased integration of artificial intelligence and multiplex testing platforms, further enhancing diagnostic accuracy and efficiency. The US autoimmunity diagnostics market reflects strong demand from both hospital laboratories and independent diagnostic centers.
- The US healthcare system's emphasis on precision medicine and preventive care supports sustained market expansion through 2030..
Key Market Statistics
- CAGR (2025-2030) 7.8% CAGR
- Market Size, 2025 ~USD 1119 Million
- Forecast, 2030 ~USD 1759.4 Million
- Country US
US Autoimmunity Diagnostics Market Overview
Market Size & Growth :
The US autoimmunity diagnostics market is valued at $1,119.0 million in 2025 and is projected to reach $1,759.4 million by 2030, growing at a CAGR of 7.8%.
Rising Autoimmune Prevalence :
Increasing prevalence of autoimmune disorders across the US population is driving demand for advanced diagnostic solutions and early detection capabilities.
Healthcare Investment :
Growing US healthcare spending and insurance coverage expansion are enabling broader adoption of sophisticated autoimmunity diagnostic technologies and testing platforms.
Technology Adoption :
US healthcare providers are increasingly adopting advanced diagnostic technologies including multiplex assays, AI-driven analysis, and point-of-care testing solutions.
US Autoimmunity Diagnostics Market Dynamics
- The market benefits from robust healthcare infrastructure, significant R&D investments, and favorable reimbursement policies that support adoption of innovative diagnostic platforms.
- Technological advancements in biomarker identification and testing methodologies continue to enhance diagnostic accuracy and speed.
- The US market's maturity and high healthcare spending create opportunities for premium diagnostic solutions and specialized testing services..
Related Ecosystem
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Merck KGaA
- Shimadzu Corporation
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- The US autoimmunity diagnostics market will grow from $1,119.0M in 2025 to $1,759.4M in 2030 at a 7.8% CAGR.
- The US market is propelled by increasing autoimmune disease prevalence and advanced diagnostic technology adoption.
- The US benefits from strong reimbursement frameworks and a mature healthcare infrastructure supporting market expansion.
- The US market will see rising integration of AI-driven diagnostics and multiplex testing platforms through 2030.
Autoimmunity Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | AUTOANTIBODIES AND IMMUNOLOGIC TESTS (Test Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 8.3% from 2025 to 2030 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 5.57 (2025) |
| Revenue Forecast (Billions) | ~USD 8.29 (2030) |
| Segments Covered | Product, Test Type, Disease Type, Type, End User |
US Autoimmunity Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Test Type
- Autoantibodies And Immunologic Tests
- Inflammatory Tests
- Other Tests
- Routine Laboratory Tests
- Urinalysis Tests
By Disease Type
- Organ-Specific Autoimmune Diseases
- Systemic Autoimmune Diseases
By Type
- Celiac Disease
- Inflammatory Bowel Disease
- Multiple Sclerosis
- Other Organ-Specific Autoimmune Diseases
- Other Systemic Autoimmune Diseases
- Psoriasis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Type-1 Diabetes
By End User
- Clinical Laboratories
- Hospitals & Clinics
- Other End Users
US: AUTOIMMUNITY DIAGNOSTICS MARKET, BY END USER, 2023–2031
| Segment | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 722.2 | 758.4 | 802 | 852.7 | 978.8 | 1059.7 | 1155.1 | 1271.2 | 8 |
| HOSPITALS & CLINICS | 541.6 | 564.2 | 592 | 624.4 | 705.7 | 758.1 | 820.1 | 895.6 | 7.1 |
| OTHER END USERS | 199.5 | 206.4 | 215.1 | 225.2 | 251 | 267.7 | 287.6 | 311.9 | 6.4 |
| TOTAL | 1463.3 | 1528.9 | 1609.1 | 1702.3 | 1935.5 | 2085.5 | 2262.8 | 2478.8 | 7.5 |
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need US market data to assess market size, growth potential, and competitive dynamics for launching or expanding autoimmunity diagnostic products in the largest developed market.
- Clinical Laboratory Operators : Lab operators require market insights to understand demand trends, reimbursement rates, and technology investments needed to enhance autoimmunity testing capabilities and service offerings.
- Healthcare Investors & PE Firms : Investors need comprehensive US market analysis to evaluate investment opportunities, growth potential, and exit strategies in the autoimmunity diagnostics sector.
- Hospital & Healthcare Systems : Healthcare administrators need market data to make informed decisions about diagnostic technology adoption, vendor selection, and budget allocation for autoimmunity testing services.
- Pharmaceutical & Biotech Companies : Pharma companies require US market intelligence to understand diagnostic companion testing opportunities and develop integrated diagnostic-therapeutic strategies for autoimmune disease management.
Reasons to Buy this Report
- Market Size & Revenue Projections : Access precise US market valuation ($1,119M in 2025) and detailed 5-year forecasts to $1,759.4M, enabling accurate financial planning and investment decisions for US market entry or expansion.
- Growth Drivers & Trends : Understand key US-specific growth catalysts including rising autoimmune prevalence, healthcare spending patterns, and technology adoption rates to identify market opportunities and competitive positioning.
- Competitive Landscape Intelligence : Gain insights into the US competitive environment, market consolidation trends, and strategic positioning of diagnostic providers to inform go-to-market strategies and partnership opportunities.
- Regulatory & Reimbursement Insights : Obtain detailed analysis of US FDA regulations, insurance coverage policies, and reimbursement frameworks that directly impact market accessibility and profitability for diagnostic solutions.
- Customer Segmentation Data : Identify and understand US customer segments including hospitals, diagnostic labs, and specialty clinics to tailor product development, marketing strategies, and sales approaches effectively.
Frequently asked questions
What is the current size of the US autoimmunity diagnostics market?
The US autoimmunity diagnostics market is valued at $1,119.0 million in 2025.
What is the projected size of the US autoimmunity diagnostics market by 2030?
The US autoimmunity diagnostics market is projected to reach $1,759.4 million by 2030.
What is the CAGR for the US autoimmunity diagnostics market?
The US autoimmunity diagnostics market is expected to grow at a compound annual growth rate of 7.8% from 2025 to 2030.
What factors are driving growth in the US autoimmunity diagnostics market?
Growth in the US market is driven by rising autoimmune disease prevalence, increased healthcare spending, advanced diagnostic technology adoption, and strong reimbursement policies.
Which technologies are emerging in the US autoimmunity diagnostics market?
The US market is seeing increased adoption of artificial intelligence-driven diagnostics, multiplex testing platforms, and precision medicine approaches through 2030.
RESEARCH METHODOLOGY
The study involved estimating activities to determine the current size of the autoimmunity diagnostics market. Exhaustive secondary research was done to collect information on the autoimmunity diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the autoimmunity diagnostics market.
Secondary Research
Various sources were utilized to gather information for this study in the secondary research process. These sources included company annual reports, press releases, and investor presentations; white papers; certified publications; articles by recognized authors; reputable websites; and information from regulatory bodies and databases, such as D&B Hoovers, Bloomberg Business, and Factiva.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott Laboratories (US) | Product Specialist |
| Thermo Fisher Scientific Inc. (US) | Clinical Sales Specialist |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the autoimmunity diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry were identified through extensive secondary research.
- Primary and secondary research determined the revenues generated by leading players operating in the autoimmunity diagnostics market.
- All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments after arriving at the overall market size by applying the abovementioned process. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Autoimmune diseases are defined as a medical condition in which an individual's immune system produces antibodies that attack the body's normal tissues. autoimmunity diagnostics systematically identifies autoimmune disorders through clinical assessment and laboratory investigations to detect immune system dysfunction. This process typically involves routine laboratory testing, measurement of systemic inflammatory markers, detection of disease-specific autoantibodies, urinalysis, and other specialized immunologic assays.
Stakeholders
- Manufacturers & distributors of autoimmunity diagnostics products
- Clinical laboratories
- Hospitals
- Research institutes
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global autoimmunity diagnostics market, by product, test type, disease type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall autoimmunity diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
Get the Full Autoimmunity Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Autoimmunity Diagnostics Market.
- Canada Autoimmunity Diagnostics Market
- UK Autoimmunity Diagnostics Market
- Germany Autoimmunity Diagnostics Market
- France Autoimmunity Diagnostics Market
- Italy Autoimmunity Diagnostics Market
- Spain Autoimmunity Diagnostics Market
- China Autoimmunity Diagnostics Market
- Japan Autoimmunity Diagnostics Market
- India Autoimmunity Diagnostics Market
- Australia Autoimmunity Diagnostics Market
- Rest Of Europe Autoimmunity Diagnostics Market
- Rest Of Asia Pacific Autoimmunity Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
